Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Arcellx, Inc. Common Stock
IPO Date: February 4, 2022
Sector: Healthcare
Industry: Biotech
Market Cap: $3.94B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.15 | 2.74%
Avg Daily Range (30 D): $1.03 | 1.46%
Avg Daily Range (90 D): $1.26 | 1.92%
Institutional Daily Volume
Avg Daily Volume: .42M
Avg Daily Volume (30 D): .43M
Avg Daily Volume (90 D): .52M
Trade Size
Avg Trade Size (Sh.): 52
Avg Trade Size (Sh.) (30 D): 48
Avg Trade Size (Sh.) (90 D): 49
Institutional Trades
Total Inst.Trades: 1,969
Avg Inst. Trade: $2.65M
Avg Inst. Trade (30 D): $4.78M
Avg Inst. Trade (90 D): $3.52M
Avg Inst. Trade Volume: .05M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.1M
Avg Closing Trade (30 D): $4.94M
Avg Closing Trade (90 D): $5.45M
Avg Closing Volume: 80.51K
   
News
May 23, 2025 @ 1:10 PM
New Data and Deal Flow Signal a Turning Point for ...
Source: Prnewswire
May 12, 2025 @ 5:00 PM
Blood Cancer Treatment Market Sees Accelerated Gro...
Source: Delveinsight
Mar 5, 2025 @ 6:00 PM
CAR T-cell Therapy Clinical Trial Pipeline Experie...
Source: Delveinsight
Feb 12, 2025 @ 8:22 PM
Gilead Ups 2025 Outlook, Eyes Lenacapavir Launch F...
Source: Vandana Singh
May 31, 2024 @ 12:01 PM
Expert Ratings For Arcellx
Source: Benzinga Insights
Financials
  TTM Q2 2025 Q1 2025
Basic EPS $-.94 $-1.13
Diluted EPS $-.94 $-1.13
Revenue $ $ 7.55M $ 8.13M
Gross Profit $ $ $
Net Income / Loss $ $ -52.77M $ -62.27M
Operating Income / Loss $ $ -58.73M $ -68.9M
Cost of Revenue $ $ $
Net Cash Flow $ $ -18.73M $ -24.82M
PE Ratio